Author:
Albrecht Jana Dorothea,Nicolay Jan Peter
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood 127:2375–2390
2. Kim YH, Willemze R, Pimpinelli N et al (2007) TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the international society for cutaneous lymphomas (ISCL) and the cutaneous lymphoma task force of the European organization of research and treatment of cancer (EORTC). Blood 110:479–484
3. Dippel ECA, Becker JC, von Bergwelt-Baildon M, Bernreiter S, Cozzio A, Eich HT, Elsayad K, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke C‑D, Loquai C, Meiss F, Mitteldorf C, Wehkamp U, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stranzenbach R, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R (2021) S2k-Leitlinie – Kutane Lymphome (ICD10 C82–C86) Update 2021. https://www.awmf.org/uploads/tx_szleitlinien/032-027l_S2k_Kutane_Lymphome_2021-09.pdf. Zugegriffen: 19. Dez. 2021
4. Dobos G, Pohrt A, Ram-Wolff C et al (2020) Epidemiology of cutaneous T‑cell lymphomas: a systematic review and meta-analysis of 16,953 patients. Cancers (Basel) 12(10):2921. https://doi.org/10.3390/cancers12102921
5. Pulitzer M (2017) Cutaneous T‑cell lymphoma. Clin Lab Med 37:527–546